---
document_datetime: 2026-01-07 16:18:13
document_pages: 10
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zercepac-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: zercepac-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 6.4284756
conversion_datetime: 2026-01-10 10:49:00.60477
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.1
  docling: 2.67.0
  docling-core: 2.58.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Zercepac

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                           |
|----------------------|-----------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------|
| PSUSA/3010/ 202409   | Periodic Safety Update EU Single assessment - trastuzumab | 08/05/2025                          | n/a                                         |                                  | PRAC Recommendation - maintenance |
| R/0039               | Renewal of the marketing authorisation.                   | 30/01/2025                          | 04/04/2025                                  |                                  |                                   |
| IB/0040/G            | This was an application for a group of variations.        | 03/12/2024                          | n/a                                         |                                  |                                   |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation   |            |            |                    |         |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------------|---------|
| IB/0038   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 12/11/2024 | n/a        |                    |         |
| IB/0036/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.e.5.c - Implementation of changes foreseen in an approved change management protocol - For a biological/immunological medicinal product B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New site of MCB and/or WCB                                                                                                                                                                                                               | 27/09/2024 | 04/04/2025 | SmPC and Labelling | storage |

<div style=\"page-break-after: always\"></div>

| IA/0037   | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                                                                                                                                                                                                                                                                                                                        | 07/08/2024   | n/a        |    |           |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----|-----------|
| N/0035    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                             | 25/07/2024   | 04/04/2025 | PL |           |
| IB/0033   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                | 21/06/2024   | n/a        |    |           |
|           | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 04/06/2024   | n/a        |    | IA/0034/G |
| IB/0032   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                         | 07/12/2023   | n/a        |    |           |
| IB/0031/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 10/11/2023   | n/a        |    |           |

<div style=\"page-break-after: always\"></div>

|           | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                          |            |     |          |                  |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------|------------------|
| IB/0030/G | This was an application for a group of variations. B.II.b.4.z - Change in the batch size (including batch size ranges) of the finished product - Other variation B.I.a.3.z - Change in batch size (including batch size intermediate - Other variation                                             | 12/09/2023 | n/a |          | ranges) of AS or |
| II/0021   | B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release/control, and secondary packaging, for biol/immunol medicinal products or pharmaceutical forms manufactured by complex manufacturing processes | 31/08/2023 | n/a |          |                  |
| IA/0029   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                      | 10/07/2023 |     | Annex II |                  |
|           | This was an application for a group of variations. B.I.d.1.c - Stability of AS - Change in the re-test period/storage period or storage conditions - Change to an approved stability protocol B.II.f.1.e - Stability of FP - Change to an approved stability protocol                              | 04/07/2023 | n/a |          | IB/0028/G        |

<div style=\"page-break-after: always\"></div>

| IB/0027   | B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition                                                                                                                                                                                                                                                                                                                                                            | 16/05/2023   | n/a   |      |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|------|
| IB/0026   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                | 17/03/2023   | n/a   |      |
| IA/0025   | A.6 - Administrative change - Change in ATC Code/ATC Vet Code                                                                                                                                                                                                                                                                                                                                                                                                | 07/02/2023   |       | SmPC |
| II/0022   | B.I.e.2 - Introduction of a post approval change management protocol related to the AS                                                                                                                                                                                                                                                                                                                                                                       | 19/01/2023   | n/a   |      |
| II/0020   | Submission of the final report from study HLX02- BC01 in order to fulfil REC/006. This is a double- blind, randomised, parallel-controlled, multicentre, international, phase 3 study to compare the efficacy, safety, and immunogenicity of HLX02 versus EU- sourced Herceptin in combination with docetaxel. C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority | 12/01/2023   | n/a   |      |
| IA/0024   | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                   | 16/12/2022   | n/a   |      |
| IAIN/0023 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                                                                                                                                                                                                                                                | 16/12/2022   | n/a   |      |

<div style=\"page-break-after: always\"></div>

|                    | site                                                                                                                                                                                                                                                                                                |            |     |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| II/0016            | B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release/control, and secondary packaging, for biol/immunol medicinal products or pharmaceutical forms manufactured by complex manufacturing processes  | 24/11/2022 | n/a |                                   |
| PSUSA/3010/ 202109 | Periodic Safety Update EU Single assessment - trastuzumab                                                                                                                                                                                                                                           | 10/06/2022 | n/a | PRAC Recommendation - maintenance |
| IB/0019/G          | This was an application for a group of variations. B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test B.II.e.z - Change in container closure system of the Finished Product - Other variation | 07/04/2022 | n/a |                                   |
| IB/0018            | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                        | 04/02/2022 | n/a |                                   |
| II/0015/G          | This was an application for a group of variations. B.I.c.1.b - Change in immediate packaging of the AS - Qualitative and/or quantitative composition for sterile and non-frozen biological/immunological ASs                                                                                        | 13/01/2022 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|           | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                      |            |            |             |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| II/0013/G | This was an application for a group of variations. B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.I.a.1.e - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The change relates to a biological AS or a starting material [-] used in the manufacture of a biological/immunological product | 11/11/2021 | 31/10/2022 | Annex II    |
| IB/0014   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                      | 28/10/2021 | 15/11/2021 | SmPC and PL |
| IB/0012/G | This was an application for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                      | 17/09/2021 | n/a        |             |

<div style=\"page-break-after: always\"></div>

| IB/0011     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                               | 09/08/2021   | 15/11/2021   | SmPC and PL            | To update sections 4.6, 6.6 of the SmPC to update the safety information following assessment of the same change for the reference product.   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0010/G | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) | 14/07/2021   | 15/11/2021   | Annex II and PL        |                                                                                                                                               |
| II/0008     | B.II.e.5.c - Change in pack size of the finished product - Change in the fill weight/fill volume of sterile multidose (or single-dose, partial use) parenteral medicinal products, including biological/immunological medicinal products                                                                                                                                                                                                                                                   | 20/05/2021   | 15/11/2021   | SmPC, Labelling and PL |                                                                                                                                               |
| IB/0006     | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                       | 15/02/2021   | n/a          |                        |                                                                                                                                               |
| II/0003     | B.II.e.5.c - Change in pack size of the finished product - Change in the fill weight/fill volume of sterile multidose (or single-dose, partial use)                                                                                                                                                                                                                                                                                                                                        | 11/02/2021   | 15/11/2021   | SmPC, Labelling and    |                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

|           | parenteral medicinal products, including biological/immunological medicinal products                                                                                                                                                                                                                                                                                                                    |            |            | PL          |           |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------|
| IB/0009/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process             | 29/01/2021 | n/a        |             | of the AS |
| IB/0007/G | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other | 27/01/2021 | n/a        |             | variation |
| IB/0005   | B.II.f.1.b.3 - Stability of FP - Extension of the shelf life of the finished product - After dilution or reconstitution (supported by real time data)                                                                                                                                                                                                                                                   | 27/01/2021 | 15/11/2021 | SmPC and PL |           |

<div style=\"page-break-after: always\"></div>

| IB/0004   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                  | 04/12/2020   | 15/11/2021   | SmPC and PL   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|
| IB/0002   | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                                                                                                                          | 25/11/2020   | n/a          |               |
| IB/0001/G | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol | 06/11/2020   | 15/11/2021   | SmPC          |